Virtual Exercise Rehabilitation Treatment Program for Post Exacerbation of Chronic Obstructive Pulmonary Disease
VERTEX
1 other identifier
observational
40
1 country
1
Brief Summary
Respiratory rehabilitation is an intervention proven to improve quality of life in those with chronic lung disease but access remains poor. The investigators will assess the feasibility and acceptability of a virtual platform for respiratory rehabilitation as an alternative to in person rehabilitation. The aim is to use the technology in those post admission with COPD where access has been even more of a challenge as during this period patients find it difficult to access an out patient program due to their frailty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2021
CompletedFirst Posted
Study publicly available on registry
September 16, 2021
CompletedStudy Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2023
CompletedNovember 14, 2022
November 1, 2022
1.2 years
September 5, 2021
November 9, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
6 minute walk test distance
The distance walked during the 6 minute
1 year
1-MSTST
One-minute sit to stand test
1 year
Other Outcomes (1)
Daily activity levels
1 year
Study Arms (1)
Virtual rehabilitation
Virtual pulmonary rehabilitation will be provided by a tablet with connection to a physiotherapist for monitored exercise sessions with educational videos provided on the tablet.
Interventions
Patient who are assigned to this group will receive virtual rehabilitation
Eligibility Criteria
Admitted patients \>40years of age with documented diagnosis of COPD
You may qualify if:
- minimum age of 18 years
- maximum age of 90 years
- diagnosis of COPD
You may not qualify if:
- inability to perform exercise
- severe debilitating conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Joseph's Healthcare Hamiltonlead
- Boehringer Ingelheimcollaborator
Study Sites (1)
St. Josephs' Hospital, Hamilton
Hamilton, Ontario, L8N 4A6, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 5, 2021
First Posted
September 16, 2021
Study Start
January 1, 2022
Primary Completion
March 1, 2023
Study Completion
October 1, 2023
Last Updated
November 14, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share